Prostate Cancer 2000:
All epidemiological data predict an endemic rise of prostate cancer in populations with a high proportion of elderly people, leading to a major health problem. The only way to stem this evolution is early detection in organised random- ised trials. Discussion of this controversial subject is followe...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1994
|
Schriftenreihe: | ESO Monographs, European School of Oncology
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | All epidemiological data predict an endemic rise of prostate cancer in populations with a high proportion of elderly people, leading to a major health problem. The only way to stem this evolution is early detection in organised random- ised trials. Discussion of this controversial subject is followed by an exhaustive review of the endocrine mechanisms stimulating prostate growth and the promising avenues of future research and treatment. Radical prostatectomy and radiotherapy are presented and analysed. Once patients are past this stage of cure, a wide array of medical treatments are available. Endocrine treatment is the first choice, and the different regimes are reviewed as to their respective advantages and side effects. An entirely new approach to hormone refractory diseases completes this overview |
Beschreibung: | 1 Online-Ressource (VII, 94 p) |
ISBN: | 9783642791789 |
DOI: | 10.1007/978-3-642-79178-9 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046145848 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1994 |||| o||u| ||||||eng d | ||
020 | |a 9783642791789 |9 978-3-642-79178-9 | ||
024 | 7 | |a 10.1007/978-3-642-79178-9 |2 doi | |
035 | |a (ZDB-2-SME)978-3-642-79178-9 | ||
035 | |a (OCoLC)1119011093 | ||
035 | |a (DE-599)BVBBV046145848 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.994 |2 23 | |
084 | |a XH 8000 |0 (DE-625)152949:13129 |2 rvk | ||
245 | 1 | 0 | |a Prostate Cancer 2000 |c edited by Louis Denis |
264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1994 | |
300 | |a 1 Online-Ressource (VII, 94 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a ESO Monographs, European School of Oncology | |
520 | |a All epidemiological data predict an endemic rise of prostate cancer in populations with a high proportion of elderly people, leading to a major health problem. The only way to stem this evolution is early detection in organised random- ised trials. Discussion of this controversial subject is followed by an exhaustive review of the endocrine mechanisms stimulating prostate growth and the promising avenues of future research and treatment. Radical prostatectomy and radiotherapy are presented and analysed. Once patients are past this stage of cure, a wide array of medical treatments are available. Endocrine treatment is the first choice, and the different regimes are reviewed as to their respective advantages and side effects. An entirely new approach to hormone refractory diseases completes this overview | ||
650 | 4 | |a Oncology | |
650 | 4 | |a Oncology | |
650 | 0 | 7 | |a Prostatakrebs |0 (DE-588)4047511-6 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Prostatakrebs |0 (DE-588)4047511-6 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Denis, Louis |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642791802 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540582960 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642791796 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-79178-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526033 | ||
966 | e | |u https://doi.org/10.1007/978-3-642-79178-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180483035103232 |
---|---|
any_adam_object | |
author2 | Denis, Louis |
author2_role | edt |
author2_variant | l d ld |
author_facet | Denis, Louis |
building | Verbundindex |
bvnumber | BV046145848 |
classification_rvk | XH 8000 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-642-79178-9 (OCoLC)1119011093 (DE-599)BVBBV046145848 |
dewey-full | 616.994 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.994 |
dewey-search | 616.994 |
dewey-sort | 3616.994 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-642-79178-9 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02530nmm a2200481zc 4500</leader><controlfield tag="001">BV046145848</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1994 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642791789</subfield><subfield code="9">978-3-642-79178-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-79178-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-79178-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119011093</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145848</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8000</subfield><subfield code="0">(DE-625)152949:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prostate Cancer 2000</subfield><subfield code="c">edited by Louis Denis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VII, 94 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">ESO Monographs, European School of Oncology</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">All epidemiological data predict an endemic rise of prostate cancer in populations with a high proportion of elderly people, leading to a major health problem. The only way to stem this evolution is early detection in organised random- ised trials. Discussion of this controversial subject is followed by an exhaustive review of the endocrine mechanisms stimulating prostate growth and the promising avenues of future research and treatment. Radical prostatectomy and radiotherapy are presented and analysed. Once patients are past this stage of cure, a wide array of medical treatments are available. Endocrine treatment is the first choice, and the different regimes are reviewed as to their respective advantages and side effects. An entirely new approach to hormone refractory diseases completes this overview</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Denis, Louis</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642791802</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540582960</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642791796</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-79178-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526033</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-79178-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV046145848 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:28Z |
institution | BVB |
isbn | 9783642791789 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526033 |
oclc_num | 1119011093 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (VII, 94 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1994 |
publishDateSearch | 1994 |
publishDateSort | 1994 |
publisher | Springer Berlin Heidelberg |
record_format | marc |
series2 | ESO Monographs, European School of Oncology |
spelling | Prostate Cancer 2000 edited by Louis Denis Berlin, Heidelberg Springer Berlin Heidelberg 1994 1 Online-Ressource (VII, 94 p) txt rdacontent c rdamedia cr rdacarrier ESO Monographs, European School of Oncology All epidemiological data predict an endemic rise of prostate cancer in populations with a high proportion of elderly people, leading to a major health problem. The only way to stem this evolution is early detection in organised random- ised trials. Discussion of this controversial subject is followed by an exhaustive review of the endocrine mechanisms stimulating prostate growth and the promising avenues of future research and treatment. Radical prostatectomy and radiotherapy are presented and analysed. Once patients are past this stage of cure, a wide array of medical treatments are available. Endocrine treatment is the first choice, and the different regimes are reviewed as to their respective advantages and side effects. An entirely new approach to hormone refractory diseases completes this overview Oncology Oncology Prostatakrebs (DE-588)4047511-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Prostatakrebs (DE-588)4047511-6 s DE-604 Denis, Louis edt Erscheint auch als Druck-Ausgabe 9783642791802 Erscheint auch als Druck-Ausgabe 9783540582960 Erscheint auch als Druck-Ausgabe 9783642791796 https://doi.org/10.1007/978-3-642-79178-9 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Prostate Cancer 2000 Oncology Oncology Prostatakrebs (DE-588)4047511-6 gnd |
subject_GND | (DE-588)4047511-6 (DE-588)1071861417 |
title | Prostate Cancer 2000 |
title_auth | Prostate Cancer 2000 |
title_exact_search | Prostate Cancer 2000 |
title_full | Prostate Cancer 2000 edited by Louis Denis |
title_fullStr | Prostate Cancer 2000 edited by Louis Denis |
title_full_unstemmed | Prostate Cancer 2000 edited by Louis Denis |
title_short | Prostate Cancer 2000 |
title_sort | prostate cancer 2000 |
topic | Oncology Oncology Prostatakrebs (DE-588)4047511-6 gnd |
topic_facet | Oncology Oncology Prostatakrebs Konferenzschrift |
url | https://doi.org/10.1007/978-3-642-79178-9 |
work_keys_str_mv | AT denislouis prostatecancer2000 |